Skip to main content
Top
Published in: Medicine, Health Care and Philosophy 3/2022

Open Access 24-05-2022 | Scientific Contribution

The ethical anatomy of payment for research participants

Author: Joanna Różyńska

Published in: Medicine, Health Care and Philosophy | Issue 3/2022

Login to get access

Abstract

In contrast to most publications on the ethics of paying research subjects, which start by identifying and analyzing major ethical concerns raised by the practice (in particular, risks of undue inducement and exploitation) and end with a set of—more or less well-justified—ethical recommendations for using payment schemes immune to these problems, this paper offers a systematic, principle-based ethical analysis of the practice. It argues that researchers have a prima facie moral obligation to offer payment to research subjects, which stems from the principle of social beneficence. This principle constitutes an ethical “spine” of the practice. Other ethical principles of research ethics (respect for autonomy, individual beneficence, and justice/fairness) make up an ethical “skeleton” of morally sound payment schemes by providing additional moral reasons for offering participants (1) recompense for reasonable expenses; and (2a) remuneration conceptualized as a reward for their valuable contribution, provided (i) it meets standards of equality, adequacy and non-exploitation, and (ii) it is not overly attractive (i.e., it does not constitute undue inducement for participation or retention, and does not encourage deceptive behaviors); or (2b) remuneration conceptualized as a market-driven price, provided (i) it is necessary and designed to help the study achieve its social and scientific goals, (ii) it does not reinforce wider social injustices and inequalities; (iii) it meets the requirement of non-exploitation; and (iv) it is not overly attractive. The principle of justice provides a strong ethical reason for not offering recompenses for lost wages (or loss of other reasonably expected profits).
Footnotes
1
This is an improved version of the payment typology presented in Różyńska (2021).
 
2
Developing an appropriate understanding of a common good, also referred to as a public, social or collective good, is a challenge that cannot be addressed here. For the sake of this analysis, I use all these terms interchangeably, as is frequently done in the literature. My understanding of a common good is based on the conceptual analysis provided by Hans Radder (2017). It is also inspired by Alex London’s idea of “the generic interests conception of the common good” by assuming that a social practice or policy is socially valuable when it overall promotes “a subset of interests that are sufficiently basic or fundamental to individuals that they are common to each of the members of the community… interests in being able to develop their intellectual and affective capacities in order to pursue activities that they find meaningful, and to engage in meaningful relationships with others” (2003, p. 21).
 
Literature
go back to reference Abadie, Roberto. 2010. The professional guinea pig: Big pharma and the risky world of human subjects. Durham: Duke University Press.CrossRef Abadie, Roberto. 2010. The professional guinea pig: Big pharma and the risky world of human subjects. Durham: Duke University Press.CrossRef
go back to reference Abadie, Roberto. 2015. The “mild-torture economy”: exploring the world of professional research subjects and its ethical implications. Physis: Revista De Saúde Coletiva 25: 709–728.CrossRef Abadie, Roberto. 2015. The “mild-torture economy”: exploring the world of professional research subjects and its ethical implications. Physis: Revista De Saúde Coletiva 25: 709–728.CrossRef
go back to reference Ackerman, Terrence F. 1989. An ethical framework for the practice of paying research subjects. IRB: Ethics & Human Research 11 (4): 1–4.CrossRef Ackerman, Terrence F. 1989. An ethical framework for the practice of paying research subjects. IRB: Ethics & Human Research 11 (4): 1–4.CrossRef
go back to reference Almeida, Luis, Benedita Azevedo, Teresa Nunes, Manuel Vaz-da-Silva, and Patricio Soares-da-Silva. 2007. Why healthy subjects volunteer for phase I studies and how they perceive their participation? European Journal of Clinical Pharmacology 63 (11): 1085–1094.CrossRef Almeida, Luis, Benedita Azevedo, Teresa Nunes, Manuel Vaz-da-Silva, and Patricio Soares-da-Silva. 2007. Why healthy subjects volunteer for phase I studies and how they perceive their participation? European Journal of Clinical Pharmacology 63 (11): 1085–1094.CrossRef
go back to reference Altman, Douglas G. 1980. Statistics and ethics in medical research: III How large a sample? British Medical Journal 281 (6251): 1336–1338.CrossRef Altman, Douglas G. 1980. Statistics and ethics in medical research: III How large a sample? British Medical Journal 281 (6251): 1336–1338.CrossRef
go back to reference Anderson, James A., and Charles Weijer. 2002. The research subject as wage earner. Theoretical Medicine and Bioethics 23 (4): 359–376.CrossRef Anderson, James A., and Charles Weijer. 2002. The research subject as wage earner. Theoretical Medicine and Bioethics 23 (4): 359–376.CrossRef
go back to reference Beauchamp, Tom L., and James F. Childress. 2001. The principles of biomedical ethics, 5th ed. Oxford: Oxford University Press. Beauchamp, Tom L., and James F. Childress. 2001. The principles of biomedical ethics, 5th ed. Oxford: Oxford University Press.
go back to reference Belfrage, Sara. 2016. Exploitative, irresistible, and coercive offers: Why research participants should be paid well or not at all. Journal of Global Ethics 12 (1): 69–86.CrossRef Belfrage, Sara. 2016. Exploitative, irresistible, and coercive offers: Why research participants should be paid well or not at all. Journal of Global Ethics 12 (1): 69–86.CrossRef
go back to reference Bell, Jennifer A.H.., and Lynda G. Balneaves. 2015. Cancer patient decision making related to clinical trial participation: An integrative review with implications for patients’ relational autonomy. Supportive Care in Cancer 23 (4): 1169–1196.CrossRef Bell, Jennifer A.H.., and Lynda G. Balneaves. 2015. Cancer patient decision making related to clinical trial participation: An integrative review with implications for patients’ relational autonomy. Supportive Care in Cancer 23 (4): 1169–1196.CrossRef
go back to reference Bentley, John P., and Paul G. Thacker. 2004. The influence of risk and monetary payment on the research participation decision making process. Journal of Medical Ethics 30 (3): 293–298.CrossRef Bentley, John P., and Paul G. Thacker. 2004. The influence of risk and monetary payment on the research participation decision making process. Journal of Medical Ethics 30 (3): 293–298.CrossRef
go back to reference Caldwell, Patrina H., Sana Hamilton, Alvin Tan, and Jonathan C. Craig. 2010. Strategies for increasing recruitment to randomised controlled trials: Systematic review. PLoS Medicine 7 (11): e1000368.CrossRef Caldwell, Patrina H., Sana Hamilton, Alvin Tan, and Jonathan C. Craig. 2010. Strategies for increasing recruitment to randomised controlled trials: Systematic review. PLoS Medicine 7 (11): e1000368.CrossRef
go back to reference Carlisle, Benjamin, Jonathan Kimmelman, Tim Ramsay, and Nathalie MacKinnon. 2015. Unsuccessful trial accrual and human subjects protections: An empirical analysis of recently closed trials. Clinical Trials 12 (1): 77–83.CrossRef Carlisle, Benjamin, Jonathan Kimmelman, Tim Ramsay, and Nathalie MacKinnon. 2015. Unsuccessful trial accrual and human subjects protections: An empirical analysis of recently closed trials. Clinical Trials 12 (1): 77–83.CrossRef
go back to reference Chambers, Tod. 2001. Participation as commodity, participation as gift. American Journal of Bioethics 1 (2): 48–48.CrossRef Chambers, Tod. 2001. Participation as commodity, participation as gift. American Journal of Bioethics 1 (2): 48–48.CrossRef
go back to reference Chino, Fumiko, and S Yousuf Zafar. 2019. Financial toxicity and equitable access to clinical trials. American Society of Clinical Oncology Educational Book 39: 11–18.CrossRef Chino, Fumiko, and S Yousuf Zafar. 2019. Financial toxicity and equitable access to clinical trials. American Society of Clinical Oncology Educational Book 39: 11–18.CrossRef
go back to reference Cooper, Melinda, and Catherine Waldby. 2014. Clinical labor: tissue donors and research subjects in the global bioeconomy. Durham: Duke University Press.CrossRef Cooper, Melinda, and Catherine Waldby. 2014. Clinical labor: tissue donors and research subjects in the global bioeconomy. Durham: Duke University Press.CrossRef
go back to reference Council of Europe. 2005a. Additional Protocol to Convention on human rights and biomedicine concerning biomedical research. CETS 195. Strasbourg: Council of Europe. https://rm.coe.int/168008371a. Accessed 28 Aug 2021. Council of Europe. 2005a. Additional Protocol to Convention on human rights and biomedicine concerning biomedical research. CETS 195. Strasbourg: Council of Europe. https://​rm.​coe.​int/​168008371a. Accessed 28 Aug 2021.
go back to reference Council of Europe. 2005b. Explanatory report to Additional Protocol to Convention on human rights and biomedicine concerning biomedical research. Strasbourg: Council of Europe. https://rm.coe.int/16800d3810. Accessed 28 Aug 2021. Council of Europe. 2005b. Explanatory report to Additional Protocol to Convention on human rights and biomedicine concerning biomedical research. Strasbourg: Council of Europe. https://​rm.​coe.​int/​16800d3810. Accessed 28 Aug 2021.
go back to reference Cryder, Cynthia E., Alex J. London, Kevin G. Volpp, and George Loewenstein. 2010. Informative inducement: Study payment as a signal of risk. Social Science & Medicine 70 (3): 455–464.CrossRef Cryder, Cynthia E., Alex J. London, Kevin G. Volpp, and George Loewenstein. 2010. Informative inducement: Study payment as a signal of risk. Social Science & Medicine 70 (3): 455–464.CrossRef
go back to reference Czarny, Matthew J., Nancy E. Kass, Charles W. Flexner, Kathryn A. Carson, Rachel K. Myers, and Ephraim J. Fuchs. 2010. Payment to healthy volunteers in clinical research: The research subject’s perspective. Clinical Pharmacology & Therapeutics 87 (3): 286–293.CrossRef Czarny, Matthew J., Nancy E. Kass, Charles W. Flexner, Kathryn A. Carson, Rachel K. Myers, and Ephraim J. Fuchs. 2010. Payment to healthy volunteers in clinical research: The research subject’s perspective. Clinical Pharmacology & Therapeutics 87 (3): 286–293.CrossRef
go back to reference Devine, Eric G., Megan E. Waters, Megan Putnam, Caitlin Surprise, Katie O’Malley, Courtney Richambault, Rachel L. Fishmana, Clifford M. Knappa, Elissa H. Pattersona, Ofra Sarid-Segala, Chris Streetera, Laurie Colanaria, and Domenic A. Ciraulo. 2013. Concealment and fabrication by experienced research subjects. Clinical Trials 10 (6): 935–948.CrossRef Devine, Eric G., Megan E. Waters, Megan Putnam, Caitlin Surprise, Katie O’Malley, Courtney Richambault, Rachel L. Fishmana, Clifford M. Knappa, Elissa H. Pattersona, Ofra Sarid-Segala, Chris Streetera, Laurie Colanaria, and Domenic A. Ciraulo. 2013. Concealment and fabrication by experienced research subjects. Clinical Trials 10 (6): 935–948.CrossRef
go back to reference Devine, Eric G., Clifford M. Knapp, Ofra Sarid-Segal, Sean M. O’Keefe, Cale Wardell, Morgan Baskett, Ashley Pecchia, Katie Ferrell, and Domenic A. Ciraulo. 2015. Payment expectations for research participation among subjects who tell the truth, subjects who conceal information, and subjects who fabricate information. Contemporary Clinical Trials 41: 55–61.CrossRef Devine, Eric G., Clifford M. Knapp, Ofra Sarid-Segal, Sean M. O’Keefe, Cale Wardell, Morgan Baskett, Ashley Pecchia, Katie Ferrell, and Domenic A. Ciraulo. 2015. Payment expectations for research participation among subjects who tell the truth, subjects who conceal information, and subjects who fabricate information. Contemporary Clinical Trials 41: 55–61.CrossRef
go back to reference Dickert, Neal W. 2009. Enrollment of economically disadvantaged participants in clinical research. AMA Journal of Ethics 11 (1): 54–60.CrossRef Dickert, Neal W. 2009. Enrollment of economically disadvantaged participants in clinical research. AMA Journal of Ethics 11 (1): 54–60.CrossRef
go back to reference Dickert, Neal W. 2013. Concealment and fabrication: The hidden price of payment for research participation? Clinical Trials 10 (6): 840–841.CrossRef Dickert, Neal W. 2013. Concealment and fabrication: The hidden price of payment for research participation? Clinical Trials 10 (6): 840–841.CrossRef
go back to reference Dickert, Neal, Ezekiel Emanuel, and Christine Grady. 2002. Paying research subjects: An analysis of current policies. Annals of Internal Medicine 136 (5): 368–373.CrossRef Dickert, Neal, Ezekiel Emanuel, and Christine Grady. 2002. Paying research subjects: An analysis of current policies. Annals of Internal Medicine 136 (5): 368–373.CrossRef
go back to reference Dickert, Neal, and Christine Grady. 1999. What’s the price of a research subject? Approaches to payment for research participation. The New England Journal of Medicine 341: 198–203.CrossRef Dickert, Neal, and Christine Grady. 1999. What’s the price of a research subject? Approaches to payment for research participation. The New England Journal of Medicine 341: 198–203.CrossRef
go back to reference Dickert, Neal, and Christine Grady. 2008. Incentives for participants. In The Oxford textbook on the ethics of clinical research, ed. Ezekiel J. Emanuel, Robert A. Crouch, Christine C. Grady, Reidar K. Lie, Franklin G. Miller, and David D. Wendler, 386–396. New York: Oxford University Press. Dickert, Neal, and Christine Grady. 2008. Incentives for participants. In The Oxford textbook on the ethics of clinical research, ed. Ezekiel J. Emanuel, Robert A. Crouch, Christine C. Grady, Reidar K. Lie, Franklin G. Miller, and David D. Wendler, 386–396. New York: Oxford University Press.
go back to reference Dresser, Rebecca. 2013. Subversive subjects: Rule-breaking and deception in clinical trials. The Journal of Law, Medicine & Ethics 41 (4): 829–840.CrossRef Dresser, Rebecca. 2013. Subversive subjects: Rule-breaking and deception in clinical trials. The Journal of Law, Medicine & Ethics 41 (4): 829–840.CrossRef
go back to reference Duncan, Peter. 2010. Health, health care and the problem of intrinsic value. Journal of Evaluation in Clinical Practice 16 (2): 318–322.CrossRef Duncan, Peter. 2010. Health, health care and the problem of intrinsic value. Journal of Evaluation in Clinical Practice 16 (2): 318–322.CrossRef
go back to reference Dunn, Laura B., and Nora E. Gordon. 2005. Improving informed consent and enhancing recruitment for research by understanding economic behavior. JAMA 293 (5): 609–612.CrossRef Dunn, Laura B., and Nora E. Gordon. 2005. Improving informed consent and enhancing recruitment for research by understanding economic behavior. JAMA 293 (5): 609–612.CrossRef
go back to reference Elliott, Carl. 2008. Guinea-pigging. The New Yorker, January 7, pp. 36−41. Elliott, Carl. 2008. Guinea-pigging. The New Yorker, January 7, pp. 36−41.
go back to reference Elliott, Carl, and Roberto Abadie. 2008. Exploiting a research underclass in phase 1 clinical trials. The New England Journal of Medicine 358 (22): 2316–2317.CrossRef Elliott, Carl, and Roberto Abadie. 2008. Exploiting a research underclass in phase 1 clinical trials. The New England Journal of Medicine 358 (22): 2316–2317.CrossRef
go back to reference Emanuel, Ezekiel J. 2004. Ending concerns about undue inducement. Journal of Law, Medicine & Ethics 32 (1): 100–105.CrossRef Emanuel, Ezekiel J. 2004. Ending concerns about undue inducement. Journal of Law, Medicine & Ethics 32 (1): 100–105.CrossRef
go back to reference Emanuel, Ezekiel J. 2005. Undue inducement: Nonsense on stilts? The American Journal of Bioethics 5 (5): 9–13.CrossRef Emanuel, Ezekiel J. 2005. Undue inducement: Nonsense on stilts? The American Journal of Bioethics 5 (5): 9–13.CrossRef
go back to reference Emanuel, Ezekiel J., David Wendler, and Christine Grady. 2000. What makes clinical research ethical? JAMA 283 (20): 2701–2711.CrossRef Emanuel, Ezekiel J., David Wendler, and Christine Grady. 2000. What makes clinical research ethical? JAMA 283 (20): 2701–2711.CrossRef
go back to reference Faden, Ruth, and Tom Beauchamp. 1986. A history and theory of informed consent. New York: Oxford University Press. Faden, Ruth, and Tom Beauchamp. 1986. A history and theory of informed consent. New York: Oxford University Press.
go back to reference Fisher, Jill A. 2019. Research payment and its social justice concerns. The American Journal of Bioethics 19 (9): 35–36.CrossRef Fisher, Jill A. 2019. Research payment and its social justice concerns. The American Journal of Bioethics 19 (9): 35–36.CrossRef
go back to reference Fisher, Jill A., Lisa McManus, Megan M. Wood, Marci D. Cottingham, Julianne M. Kalbaugh, Torin Monahan, and Rebecca L. Walker. 2018. Healthy volunteers’ perceptions of the benefits of their participation in phase I clinical trials. Journal of Empirical Research on Human Research Ethics 13 (5): 494–510.CrossRef Fisher, Jill A., Lisa McManus, Megan M. Wood, Marci D. Cottingham, Julianne M. Kalbaugh, Torin Monahan, and Rebecca L. Walker. 2018. Healthy volunteers’ perceptions of the benefits of their participation in phase I clinical trials. Journal of Empirical Research on Human Research Ethics 13 (5): 494–510.CrossRef
go back to reference Fisher, Jill A., Torin Monahan, and Rebecca L. Walker. 2019. Picking and choosing among phase I trials. Journal of Bioethical Inquiry 16 (4): 535–549.CrossRef Fisher, Jill A., Torin Monahan, and Rebecca L. Walker. 2019. Picking and choosing among phase I trials. Journal of Bioethical Inquiry 16 (4): 535–549.CrossRef
go back to reference Friedman, Daniela B., Caroline Foster, Caroline D. Bergeron, Andrea Tanner, and Sei-Hill. Kim. 2015. A qualitative study of recruitment barriers, motivators, and community-based strategies for increasing clinical trials participation among rural and urban populations. American Journal of Health Promotion 29 (5): 332–338.CrossRef Friedman, Daniela B., Caroline Foster, Caroline D. Bergeron, Andrea Tanner, and Sei-Hill. Kim. 2015. A qualitative study of recruitment barriers, motivators, and community-based strategies for increasing clinical trials participation among rural and urban populations. American Journal of Health Promotion 29 (5): 332–338.CrossRef
go back to reference Fry, Craig L., Alison Ritter, Simon Baldwin, Kathryn J. Bowen, T. Paul Gardiner, Rebecca Jenkinson Holt, and Jennifer Johnston. 2005. Paying research participants: A study of current practices in Australia. Journal of Medical Ethics 31 (9): 542–547.CrossRef Fry, Craig L., Alison Ritter, Simon Baldwin, Kathryn J. Bowen, T. Paul Gardiner, Rebecca Jenkinson Holt, and Jennifer Johnston. 2005. Paying research participants: A study of current practices in Australia. Journal of Medical Ethics 31 (9): 542–547.CrossRef
go back to reference Gelinas, Luke, Emily A. Largent, I. Glenn Cohen, Susan Kornetsky, Barbara E. Bierer, and Holly Fernandez Lynch. 2018. A framework for ethical payment to research participants. The New England Journal of Medicine 378 (8): 766–771.CrossRef Gelinas, Luke, Emily A. Largent, I. Glenn Cohen, Susan Kornetsky, Barbara E. Bierer, and Holly Fernandez Lynch. 2018. A framework for ethical payment to research participants. The New England Journal of Medicine 378 (8): 766–771.CrossRef
go back to reference Gelinas, Luke, Sarah A. White, and Barbara E. Bierer. 2020. Economic vulnerability and payment for research participation. Clinical Trials 17 (3): 264–272.CrossRef Gelinas, Luke, Sarah A. White, and Barbara E. Bierer. 2020. Economic vulnerability and payment for research participation. Clinical Trials 17 (3): 264–272.CrossRef
go back to reference Geller, Stacie E., Abby Koch, Beth Pellettieri, and Molly Carnes. 2011. Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: Have we made progress? Journal of Women’s Health 20 (3): 315–320.CrossRef Geller, Stacie E., Abby Koch, Beth Pellettieri, and Molly Carnes. 2011. Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: Have we made progress? Journal of Women’s Health 20 (3): 315–320.CrossRef
go back to reference Glannon, William. 2006. Phase I oncology trials: Why the therapeutic misconception will not go away. Journal of Medical Ethics 32: 252–255.CrossRef Glannon, William. 2006. Phase I oncology trials: Why the therapeutic misconception will not go away. Journal of Medical Ethics 32: 252–255.CrossRef
go back to reference Grady, Christine. 2001. Money for research participation: Does it jeopardize informed consent? The American Journal of Bioethics 1 (2): 40–44.CrossRef Grady, Christine. 2001. Money for research participation: Does it jeopardize informed consent? The American Journal of Bioethics 1 (2): 40–44.CrossRef
go back to reference Grady, Christine. 2005. Payment of clinical research subjects. The Journal of Clinical Investigation 115 (7): 1681–1687.CrossRef Grady, Christine. 2005. Payment of clinical research subjects. The Journal of Clinical Investigation 115 (7): 1681–1687.CrossRef
go back to reference Grady, Christine, Gabriella Bedarid, Ninet Sinaii, Mark A. Gregorio, and Ezekiel J. Emanuel. 2017. Motivations, enrollment decisions, and socio-demographic characteristics of healthy volunteers in phase 1 research. Clinical Trials 14 (5): 526–536.CrossRef Grady, Christine, Gabriella Bedarid, Ninet Sinaii, Mark A. Gregorio, and Ezekiel J. Emanuel. 2017. Motivations, enrollment decisions, and socio-demographic characteristics of healthy volunteers in phase 1 research. Clinical Trials 14 (5): 526–536.CrossRef
go back to reference Grady, Christine, Neal Dickert, Tom Jawetz, Gary Gensler, and Ezekiel J. Emanuel. 2005. An analysis of US practices of paying research participants. Contemporary Clinical Trials 26 (3): 365–375.CrossRef Grady, Christine, Neal Dickert, Tom Jawetz, Gary Gensler, and Ezekiel J. Emanuel. 2005. An analysis of US practices of paying research participants. Contemporary Clinical Trials 26 (3): 365–375.CrossRef
go back to reference Grant, Ruth W., and Jeremy Sugarman. 2004. Ethics in human subjects research: Do incentives matter? The Journal of Medicine and Philosophy 29 (6): 717–738.CrossRef Grant, Ruth W., and Jeremy Sugarman. 2004. Ethics in human subjects research: Do incentives matter? The Journal of Medicine and Philosophy 29 (6): 717–738.CrossRef
go back to reference Grimwade, Olivia, Julian Savulescu, Alberto Giubilini, Justin Oakley, Joshua Osowicki, Andrew J. Pollard, and Anne-Marie. Nussberger. 2020. Payment in challenge studies: Ethics, attitudes and a new payment for risk model. Journal of Medical Ethics 46 (12): 815–826.CrossRef Grimwade, Olivia, Julian Savulescu, Alberto Giubilini, Justin Oakley, Joshua Osowicki, Andrew J. Pollard, and Anne-Marie. Nussberger. 2020. Payment in challenge studies: Ethics, attitudes and a new payment for risk model. Journal of Medical Ethics 46 (12): 815–826.CrossRef
go back to reference Gul, Raisa B., and Parveen A. Ali. 2010. Clinical trials: The challenge of recruitment and retention of participants. Journal of Clinical Nursing 19 (1–2): 227–233.CrossRef Gul, Raisa B., and Parveen A. Ali. 2010. Clinical trials: The challenge of recruitment and retention of participants. Journal of Clinical Nursing 19 (1–2): 227–233.CrossRef
go back to reference Halpern, Scott D., Jason H.T.. Karlawish, and Jesse A. Berlin. 2002. The continuing unethical conduct of underpowered clinical trials. JAMA 288 (3): 358–362.CrossRef Halpern, Scott D., Jason H.T.. Karlawish, and Jesse A. Berlin. 2002. The continuing unethical conduct of underpowered clinical trials. JAMA 288 (3): 358–362.CrossRef
go back to reference Hamel, Lauren M., Louis A. Penner, Terrance L. Albrecht, Elisabeth Heath, Klement C. Gwede, and Susan Eggly. 2016. Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer. Cancer Control 23 (4): 327–337.CrossRef Hamel, Lauren M., Louis A. Penner, Terrance L. Albrecht, Elisabeth Heath, Klement C. Gwede, and Susan Eggly. 2016. Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer. Cancer Control 23 (4): 327–337.CrossRef
go back to reference Heller, Caren, Joyce E. Balls-Berry, Jill D. Nery, Patricia J. Erwin, Dawn Littleton, Mimi Kim, and Winston P. Kuo. 2014. Strategies addressing barriers to clinical trial enrollment of underrepresented populations: A systematic review. Contemporary Clinical Trials 39 (2): 169–182. Heller, Caren, Joyce E. Balls-Berry, Jill D. Nery, Patricia J. Erwin, Dawn Littleton, Mimi Kim, and Winston P. Kuo. 2014. Strategies addressing barriers to clinical trial enrollment of underrepresented populations: A systematic review. Contemporary Clinical Trials 39 (2): 169–182.
go back to reference Jamrozik, Euzebiusz, and Michael J. Selgelid. 2020. Should practice and policy be revised to allow for risk-proportional payment to human challenge study participants? Journal of Medical Ethics 46 (12): 835–836.CrossRef Jamrozik, Euzebiusz, and Michael J. Selgelid. 2020. Should practice and policy be revised to allow for risk-proportional payment to human challenge study participants? Journal of Medical Ethics 46 (12): 835–836.CrossRef
go back to reference King Reame, Nancy. 2001. Treating research subjects as unskilled wage earners: A risky business. American Journal of Bioethics 1 (2): 53–54.CrossRef King Reame, Nancy. 2001. Treating research subjects as unskilled wage earners: A risky business. American Journal of Bioethics 1 (2): 53–54.CrossRef
go back to reference Klitzman, Robert. 2013. How IRBs view and make decisions about coercion and undue influence. Journal of Medical Ethics 39 (4): 224–229.CrossRef Klitzman, Robert. 2013. How IRBs view and make decisions about coercion and undue influence. Journal of Medical Ethics 39 (4): 224–229.CrossRef
go back to reference Kwiatkowski, Kat, Kathlyn Coe, John C. Bailar, and Marie G. Swanson. 2013. Inclusion of minorities and women in cancer clinical trials, a decade later: Have we improved? Cancer 119 (16): 2956–2963.CrossRef Kwiatkowski, Kat, Kathlyn Coe, John C. Bailar, and Marie G. Swanson. 2013. Inclusion of minorities and women in cancer clinical trials, a decade later: Have we improved? Cancer 119 (16): 2956–2963.CrossRef
go back to reference Largent, Emily A., Ezekiel J. Emanuel, and Holly Fernandez Lynch. 2019. Filthy lucre or fitting offer? Understanding worries about payments to research participants. The American Journal of Bioethics 19 (9): 1–4.CrossRef Largent, Emily A., Ezekiel J. Emanuel, and Holly Fernandez Lynch. 2019. Filthy lucre or fitting offer? Understanding worries about payments to research participants. The American Journal of Bioethics 19 (9): 1–4.CrossRef
go back to reference Largent, Emily A., Christine Grady, Franklin G. Miller, and Allan Wertheimer. 2012. Money, coercion, and undue inducement: a survey of attitudes about payments to research participants. IRB 34 (1): 1–8. Largent, Emily A., Christine Grady, Franklin G. Miller, and Allan Wertheimer. 2012. Money, coercion, and undue inducement: a survey of attitudes about payments to research participants. IRB 34 (1): 1–8.
go back to reference Largent, Emily A., Christine Grady, Franklin G. Miller, and Allan Wertheimer. 2013. Misconceptions about coercion and undue influence: Reflections on the views of IRB members. Bioethics 27 (9): 500–507.CrossRef Largent, Emily A., Christine Grady, Franklin G. Miller, and Allan Wertheimer. 2013. Misconceptions about coercion and undue influence: Reflections on the views of IRB members. Bioethics 27 (9): 500–507.CrossRef
go back to reference Largent, Emily A., and Holly Fernandez Lynch. 2017a. Paying research participants: Regulatory uncertainty, conceptual confusion, and a path forward. Yale Journal of Health Policy, Law, and Ethics 17 (1): 61–141. Largent, Emily A., and Holly Fernandez Lynch. 2017a. Paying research participants: Regulatory uncertainty, conceptual confusion, and a path forward. Yale Journal of Health Policy, Law, and Ethics 17 (1): 61–141.
go back to reference Largent, Emily A., and Holly Fernandez Lynch. 2017b. Paying research participants: The outsized influence of “undue influence.” IRB 39 (4): 1–9. Largent, Emily A., and Holly Fernandez Lynch. 2017b. Paying research participants: The outsized influence of “undue influence.” IRB 39 (4): 1–9.
go back to reference Largent, Emily A., and Holly Fernandez Lynch. 2018. Addressing financial barriers to enrollment in clinical trials. JAMA Oncology 4 (7): 913–914.CrossRef Largent, Emily A., and Holly Fernandez Lynch. 2018. Addressing financial barriers to enrollment in clinical trials. JAMA Oncology 4 (7): 913–914.CrossRef
go back to reference Lee, Chuen P., Tyson Holmes, Eric Neri, and Clete A. Kushida. 2018. Deception in clinical trials and its impact on recruitment and adherence of study participants. Contemporary Clinical Trials 72: 146–157.CrossRef Lee, Chuen P., Tyson Holmes, Eric Neri, and Clete A. Kushida. 2018. Deception in clinical trials and its impact on recruitment and adherence of study participants. Contemporary Clinical Trials 72: 146–157.CrossRef
go back to reference Lemmens, Trudo, and Carl Elliott. 1999. Guinea pigs on the payroll: The ethics of paying research subjects. Accountability in Research 7 (1): 3–20.CrossRef Lemmens, Trudo, and Carl Elliott. 1999. Guinea pigs on the payroll: The ethics of paying research subjects. Accountability in Research 7 (1): 3–20.CrossRef
go back to reference Lemmens, Trudo, and Carl Elliott. 2001. Justice for the professional guinea pig. American Journal of Bioethics 1 (2): 51–53.CrossRef Lemmens, Trudo, and Carl Elliott. 2001. Justice for the professional guinea pig. American Journal of Bioethics 1 (2): 51–53.CrossRef
go back to reference London, Alex J. 2003. Threats to the common good: Biochemical weapons and human subjects research. Hastings Center Report 33 (5): 17–25. London, Alex J. 2003. Threats to the common good: Biochemical weapons and human subjects research. Hastings Center Report 33 (5): 17–25.
go back to reference London, Alex J. 2006. Reasonable risks in clinical research: A critique and a proposal for the Integrative Approach. Statistics in Medicine 25 (17): 2869–2885.CrossRef London, Alex J. 2006. Reasonable risks in clinical research: A critique and a proposal for the Integrative Approach. Statistics in Medicine 25 (17): 2869–2885.CrossRef
go back to reference London, Alex J., Jonathan Kimmelman, and Marina E. Emborg. 2010. Beyond access v. protection in trials of innovative therapies. Science 328: 829–830.CrossRef London, Alex J., Jonathan Kimmelman, and Marina E. Emborg. 2010. Beyond access v. protection in trials of innovative therapies. Science 328: 829–830.CrossRef
go back to reference Lynch, Holly F. 2014. Human research subjects as human research workers. Yale Journal of Health Policy, Law, and Ethics 14: 122–193. Lynch, Holly F. 2014. Human research subjects as human research workers. Yale Journal of Health Policy, Law, and Ethics 14: 122–193.
go back to reference Lynch, Holly F., Thomas C. Darton, Jae Levy, Frank McCormick, Ubaka Ogbogu, Puth O. Payne, Alvin E. Roth, Akilah Jefferson Shah, Thomas Smiley, and Emily A. Largent. 2021. Promoting ethical payment in human infection challenge studies. The American Journal of Bioethics 21 (3): 11–31.CrossRef Lynch, Holly F., Thomas C. Darton, Jae Levy, Frank McCormick, Ubaka Ogbogu, Puth O. Payne, Alvin E. Roth, Akilah Jefferson Shah, Thomas Smiley, and Emily A. Largent. 2021. Promoting ethical payment in human infection challenge studies. The American Journal of Bioethics 21 (3): 11–31.CrossRef
go back to reference Lynch, Holly F., and Emily A. Largent. 2020. Compensating for research risk: Permissible but not obligatory. Journal of Medical Ethics 46 (12): 827–828.CrossRef Lynch, Holly F., and Emily A. Largent. 2020. Compensating for research risk: Permissible but not obligatory. Journal of Medical Ethics 46 (12): 827–828.CrossRef
go back to reference MacKay, Douglas, and Rebecca L. Walker. 2021. Paying for fairness? Incentives and fair subject selection. The American Journal of Bioethics 21 (3): 35–37.CrossRef MacKay, Douglas, and Rebecca L. Walker. 2021. Paying for fairness? Incentives and fair subject selection. The American Journal of Bioethics 21 (3): 35–37.CrossRef
go back to reference Macklin, Ruth. 1981. ‘Due’ and ‘undue’ inducements: on paying money to research subjects. IRB: Ethics & Human Research 3 (5): 1–6.CrossRef Macklin, Ruth. 1981. ‘Due’ and ‘undue’ inducements: on paying money to research subjects. IRB: Ethics & Human Research 3 (5): 1–6.CrossRef
go back to reference Macklin, Ruth. 1989. The paradoxical case of payment as benefit to research subjects. IRB: Ethics & Human Research 11 (6): 1–3.CrossRef Macklin, Ruth. 1989. The paradoxical case of payment as benefit to research subjects. IRB: Ethics & Human Research 11 (6): 1–3.CrossRef
go back to reference Malmqvist, Erik. 2019. “Paid to endure”: Paid research participation, passivity, and the goods of work. The American Journal of Bioethics 19 (9): 11–20.CrossRef Malmqvist, Erik. 2019. “Paid to endure”: Paid research participation, passivity, and the goods of work. The American Journal of Bioethics 19 (9): 11–20.CrossRef
go back to reference McCann, Sharon K., Marion K. Campbell, and Vikki A. Entwistle. 2010. Reasons for participating in randomised controlled trials: Conditional altruism and considerations for self. Trials 11 (1): 1–10.CrossRef McCann, Sharon K., Marion K. Campbell, and Vikki A. Entwistle. 2010. Reasons for participating in randomised controlled trials: Conditional altruism and considerations for self. Trials 11 (1): 1–10.CrossRef
go back to reference McManus, Lisa, and Jill A. Fisher. 2018. To report or not to report: Exploring healthy volunteers’ rationales for disclosing adverse events in Phase I drug trials. AJOB Empirical Bioethics 9 (2): 82–90.CrossRef McManus, Lisa, and Jill A. Fisher. 2018. To report or not to report: Exploring healthy volunteers’ rationales for disclosing adverse events in Phase I drug trials. AJOB Empirical Bioethics 9 (2): 82–90.CrossRef
go back to reference McNeill, Paul. 1997. Paying people to participate in research: Why not? Bioethics 11 (5): 390–396.CrossRef McNeill, Paul. 1997. Paying people to participate in research: Why not? Bioethics 11 (5): 390–396.CrossRef
go back to reference Menikoff, Jerry. 2001. Just compensation: Paying research subjects relative to the risks they bear. The American Journal of Bioethics 1 (2): 56–58.CrossRef Menikoff, Jerry. 2001. Just compensation: Paying research subjects relative to the risks they bear. The American Journal of Bioethics 1 (2): 56–58.CrossRef
go back to reference Miller, Franklin G., and Howard Brody. 2003. A critique of clinical equipoise: Therapeutic misconception in the ethics of clinical trials. The Hastings Center Report 33 (3): 19–28.CrossRef Miller, Franklin G., and Howard Brody. 2003. A critique of clinical equipoise: Therapeutic misconception in the ethics of clinical trials. The Hastings Center Report 33 (3): 19–28.CrossRef
go back to reference Millum, Joseph, and Michael Garnett. 2019. How payment for research participation can be coercive. The American Journal of Bioethics 19 (9): 21–31.CrossRef Millum, Joseph, and Michael Garnett. 2019. How payment for research participation can be coercive. The American Journal of Bioethics 19 (9): 21–31.CrossRef
go back to reference Moriarty, Jeffrey. 2020. What’s in a wage? A new approach to the justification of pay. Business Ethics Quarterly 30 (1): 119–137.CrossRef Moriarty, Jeffrey. 2020. What’s in a wage? A new approach to the justification of pay. Business Ethics Quarterly 30 (1): 119–137.CrossRef
go back to reference Ndebele, Paul, Joseph Mfutso-Bengo, and Takafira Mduluza. 2008. Compensating clinical trial participants from limited resource settings in internationally sponsored clinical trials: A proposal. Malawi Medical Journal 20 (2): 42–45.CrossRef Ndebele, Paul, Joseph Mfutso-Bengo, and Takafira Mduluza. 2008. Compensating clinical trial participants from limited resource settings in internationally sponsored clinical trials: A proposal. Malawi Medical Journal 20 (2): 42–45.CrossRef
go back to reference Nipp, Ryan D., Kessely Hong, and Electra D. Paskett. 2019a. Overcoming barriers to clinical trial enrollment. American Society of Clinical Oncology Educational Book 39: 105–114.CrossRef Nipp, Ryan D., Kessely Hong, and Electra D. Paskett. 2019a. Overcoming barriers to clinical trial enrollment. American Society of Clinical Oncology Educational Book 39: 105–114.CrossRef
go back to reference Nipp, Ryan D., Hang Lee, Emily Gorton, Morgan Lichtenstein, Salome Kuchukhidze, Elyse Park, Bruce A. Chabner, and Beverly Moy. 2019b. Addressing the financial burden of cancer clinical trial participation: Longitudinal effects of an equity intervention. The Oncologist 24 (8): 1048–1055.CrossRef Nipp, Ryan D., Hang Lee, Emily Gorton, Morgan Lichtenstein, Salome Kuchukhidze, Elyse Park, Bruce A. Chabner, and Beverly Moy. 2019b. Addressing the financial burden of cancer clinical trial participation: Longitudinal effects of an equity intervention. The Oncologist 24 (8): 1048–1055.CrossRef
go back to reference Nussbaum, Martha C. 2013. Creating capabilities: The human development approach. Cambridge: Harvard University Press.CrossRef Nussbaum, Martha C. 2013. Creating capabilities: The human development approach. Cambridge: Harvard University Press.CrossRef
go back to reference Parkinson, Beth, Rachel Meacock, Matt Sutton, Eleonora Fichera, Nicola Mills, Gilian W. Shorter, S. Treweek, Nicola L. Harman, Rebecca P. Brown, Katie Gilies, and Peter Bower. 2019. Designing and using incentives to support recruitment and retention in clinical trials: A scoping review and a checklist for design. Trials 20 (1): 1–14.CrossRef Parkinson, Beth, Rachel Meacock, Matt Sutton, Eleonora Fichera, Nicola Mills, Gilian W. Shorter, S. Treweek, Nicola L. Harman, Rebecca P. Brown, Katie Gilies, and Peter Bower. 2019. Designing and using incentives to support recruitment and retention in clinical trials: A scoping review and a checklist for design. Trials 20 (1): 1–14.CrossRef
go back to reference Pasqualetti, Giuseppe, Giovanni Gori, Corrado Blandizzi, and Mario Del Tacca. 2010. Healthy volunteers and early phases of clinical experimentation. European Journal of Clinical Pharmacology 66 (7): 647–653.CrossRef Pasqualetti, Giuseppe, Giovanni Gori, Corrado Blandizzi, and Mario Del Tacca. 2010. Healthy volunteers and early phases of clinical experimentation. European Journal of Clinical Pharmacology 66 (7): 647–653.CrossRef
go back to reference Persad, Govind, Holly Fernandez Lynch, and Emily Largent. 2019. Differential payment to research participants in the same study: An ethical analysis. Journal of Medical Ethics 45 (5): 318–322.CrossRef Persad, Govind, Holly Fernandez Lynch, and Emily Largent. 2019. Differential payment to research participants in the same study: An ethical analysis. Journal of Medical Ethics 45 (5): 318–322.CrossRef
go back to reference Phillips, Trisha. 2011a. Exploitation in payments to research subjects. Bioethics 25 (4): 209–219.CrossRef Phillips, Trisha. 2011a. Exploitation in payments to research subjects. Bioethics 25 (4): 209–219.CrossRef
go back to reference Phillips, Trisha. 2011b. A living wage for research subjects. The Journal of Law, Medicine & Ethics 3 9(2): 243–253. Phillips, Trisha. 2011b. A living wage for research subjects. The Journal of Law, Medicine & Ethics 3 9(2): 243–253.
go back to reference Probstfield, Jeffrey L., and Robert L. Frye. 2011. Strategies for recruitment and retention of participants in clinical trials. JAMA 306 (6): 1798–1799. Probstfield, Jeffrey L., and Robert L. Frye. 2011. Strategies for recruitment and retention of participants in clinical trials. JAMA 306 (6): 1798–1799.
go back to reference Radder, Hans. 2017. Which scientific knowledge is a common good? Social Epistemology 31 (5): 431–450.CrossRef Radder, Hans. 2017. Which scientific knowledge is a common good? Social Epistemology 31 (5): 431–450.CrossRef
go back to reference Rawls, John. 1971. A theory of justice. Cambridge: Harvard University Press.CrossRef Rawls, John. 1971. A theory of justice. Cambridge: Harvard University Press.CrossRef
go back to reference Resnik, David B. 2011. Scientific research and the public trust. Science and Engineering Ethics 17 (3): 399–409.CrossRef Resnik, David B. 2011. Scientific research and the public trust. Science and Engineering Ethics 17 (3): 399–409.CrossRef
go back to reference Resnik, David B. 2015. Bioethical issues in providing financial incentives to research articipants. Medicolegal and Bioethics 5: 35–41.CrossRef Resnik, David B. 2015. Bioethical issues in providing financial incentives to research articipants. Medicolegal and Bioethics 5: 35–41.CrossRef
go back to reference Resnik, David B. 2019. Are payments to human research subjects ethically suspect? Journal of Clinical Research Best Practices 15 (6): 2374. Resnik, David B. 2019. Are payments to human research subjects ethically suspect? Journal of Clinical Research Best Practices 15 (6): 2374.
go back to reference Rhodes, Rosamond. 2010. Rethinking research ethics. The American Journal of Bioethics 10 (10): 19–36.CrossRef Rhodes, Rosamond. 2010. Rethinking research ethics. The American Journal of Bioethics 10 (10): 19–36.CrossRef
go back to reference Ripley, Elizabeth, Francis Macrina, Monika Markowitz, and Chris Gennings. 2010. Why do we pay? A national survey of investigators and IRB chairpersons. Journal of Empirical Research on Human Research Ethics 5 (3): 43–56.CrossRef Ripley, Elizabeth, Francis Macrina, Monika Markowitz, and Chris Gennings. 2010. Why do we pay? A national survey of investigators and IRB chairpersons. Journal of Empirical Research on Human Research Ethics 5 (3): 43–56.CrossRef
go back to reference Roche, Eric, Romain King, Helen M. Mohan, Blanaid Gavin, and Fiona McNicholas. 2013. Payment of research participants: Current practice and policies of Irish research ethics committees. Journal of Medical Ethics 39 (9): 591–593.CrossRef Roche, Eric, Romain King, Helen M. Mohan, Blanaid Gavin, and Fiona McNicholas. 2013. Payment of research participants: Current practice and policies of Irish research ethics committees. Journal of Medical Ethics 39 (9): 591–593.CrossRef
go back to reference Różyńska, Joanna. 2015. On the alleged right to participate in high-risk research. Bioethics 29 (7): 451–461.CrossRef Różyńska, Joanna. 2015. On the alleged right to participate in high-risk research. Bioethics 29 (7): 451–461.CrossRef
go back to reference Różyńska, Joanna. 2018. What makes clinical labour different? The case of human guinea pigging. Journal of Medical Ethics 44 (9): 638–642.CrossRef Różyńska, Joanna. 2018. What makes clinical labour different? The case of human guinea pigging. Journal of Medical Ethics 44 (9): 638–642.CrossRef
go back to reference Różyńska, Joanna. 2021. Research participants should be rewarded rather than “compensated for time and burdens.” The American Journal of Bioethics 21 (3): 53–55.CrossRef Różyńska, Joanna. 2021. Research participants should be rewarded rather than “compensated for time and burdens.” The American Journal of Bioethics 21 (3): 53–55.CrossRef
go back to reference Salman, Rustam A. S. Elaine Beller, Jonathan Kagan, Elina Hemminki, Robert S. Phillips, Julian Savulescu, Malcolm Macleod, Janet Wisley, and Iain Chalmers. 2014. Increasing value and reducing waste in biomedical research regulation and management. The Lancet 383 (9912): 176–185. Salman, Rustam A. S. Elaine Beller, Jonathan Kagan, Elina Hemminki, Robert S. Phillips, Julian Savulescu, Malcolm Macleod, Janet Wisley, and Iain Chalmers. 2014. Increasing value and reducing waste in biomedical research regulation and management. The Lancet 383 (9912): 176–185.
go back to reference Schaefer, G. Owen., Ezekiel J. Emanuel, and Alan Wertheimer. 2009. The obligation to participate in biomedical research. JAMA 302 (1): 67–72.CrossRef Schaefer, G. Owen., Ezekiel J. Emanuel, and Alan Wertheimer. 2009. The obligation to participate in biomedical research. JAMA 302 (1): 67–72.CrossRef
go back to reference Shamoo, Adil E., and David B. Resnik. 2006. Strategies to minimize risks and exploitation in phase one trials on healthy subjects. The American Journal of Bioethics 6 (3): W1–W13.CrossRef Shamoo, Adil E., and David B. Resnik. 2006. Strategies to minimize risks and exploitation in phase one trials on healthy subjects. The American Journal of Bioethics 6 (3): W1–W13.CrossRef
go back to reference Stones, Martyn, and John McMillan. 2010. Payment for participation in research: a pursuit for the poor? Journal of Medical Ethics 36 (1): 34–36. Stones, Martyn, and John McMillan. 2010. Payment for participation in research: a pursuit for the poor? Journal of Medical Ethics 36 (1): 34–36.
go back to reference Stunkel, Leanne, and Christine Grady. 2011. More than the money: A review of the literature examining healthy volunteer motivations. Contemporary Clinical Trials 32 (3): 342–352.CrossRef Stunkel, Leanne, and Christine Grady. 2011. More than the money: A review of the literature examining healthy volunteer motivations. Contemporary Clinical Trials 32 (3): 342–352.CrossRef
go back to reference Sully Ben, G., Steven A. Julious, and Jon A. Nicholl. 2013. A reinvestigation of recruitment to randomised, controlled, multicenter trials: A review of trials funded by two UK funding agencies. Trials 14: 166.CrossRef Sully Ben, G., Steven A. Julious, and Jon A. Nicholl. 2013. A reinvestigation of recruitment to randomised, controlled, multicenter trials: A review of trials funded by two UK funding agencies. Trials 14: 166.CrossRef
go back to reference Tishler, Carl L., and Suzanne Bartholomae. 2002. The recruitment of normal healthy volunteers: A review of the literature on the use of financial incentives. The Journal of Clinical Pharmacology 42 (4): 365–375.CrossRef Tishler, Carl L., and Suzanne Bartholomae. 2002. The recruitment of normal healthy volunteers: A review of the literature on the use of financial incentives. The Journal of Clinical Pharmacology 42 (4): 365–375.CrossRef
go back to reference Treweek, Shaun, Pauline Lockhart, Marie Pitkethly, Jonathan A. Cook, Monica Kjeldstrøm, Marit Johansen, Taina K. Taskila, Frank M. Sullivan, Sue Wilson, Catherine Jackson, Ritu Jones, and Elizabeth D. Mitchell. 2013. Methods to improve recruitment to randomised controlled trials: Cochrane systematic review and metaanalysis. British Medical Journal Open 3: e002360. https://doi.org/10.1136/bmjopen-2012-002360.CrossRef Treweek, Shaun, Pauline Lockhart, Marie Pitkethly, Jonathan A. Cook, Monica Kjeldstrøm, Marit Johansen, Taina K. Taskila, Frank M. Sullivan, Sue Wilson, Catherine Jackson, Ritu Jones, and Elizabeth D. Mitchell. 2013. Methods to improve recruitment to randomised controlled trials: Cochrane systematic review and metaanalysis. British Medical Journal Open 3: e002360. https://​doi.​org/​10.​1136/​bmjopen-2012-002360.CrossRef
go back to reference Unger, Joseph M., Julie R. Gralow, Kathy S. Albain, Scott D. Ramsey, and Dawn L. Hershman. 2016. Patient income level and cancer clinical trial participation: A prospective survey study. JAMA Oncology 2 (1): 137–139.CrossRef Unger, Joseph M., Julie R. Gralow, Kathy S. Albain, Scott D. Ramsey, and Dawn L. Hershman. 2016. Patient income level and cancer clinical trial participation: A prospective survey study. JAMA Oncology 2 (1): 137–139.CrossRef
go back to reference Unger, Joseph M., Dawn L. Hershman, Kathy S. Albain, Carol M. Moinpour, Judith A. Petersen, Kenda Burg, and John J. Crowley. 2013. Patient income level and cancer clinical trial participation. Journal of Clinical Oncology 31 (5): 536–542.CrossRef Unger, Joseph M., Dawn L. Hershman, Kathy S. Albain, Carol M. Moinpour, Judith A. Petersen, Kenda Burg, and John J. Crowley. 2013. Patient income level and cancer clinical trial participation. Journal of Clinical Oncology 31 (5): 536–542.CrossRef
go back to reference Unger, Joseph M., Riha Vaidya, Dawn L. Hershman, Lori M. Minasian, and Mark E. Fleury. 2019. Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation. JNCI: Journal of the National Cancer Institute 111 (3): 245–255.CrossRef Unger, Joseph M., Riha Vaidya, Dawn L. Hershman, Lori M. Minasian, and Mark E. Fleury. 2019. Systematic review and meta-analysis of the magnitude of structural, clinical, and physician and patient barriers to cancer clinical trial participation. JNCI: Journal of the National Cancer Institute 111 (3): 245–255.CrossRef
go back to reference Walker, Rebecca L., and Jill A. Fisher. 2019. “My body is one of the best commodities”: Exploring the ethics of commodification in phase i healthy volunteer clinical trials. Kennedy Institute of Ethics Journal 29 (4): 305–331.CrossRef Walker, Rebecca L., and Jill A. Fisher. 2019. “My body is one of the best commodities”: Exploring the ethics of commodification in phase i healthy volunteer clinical trials. Kennedy Institute of Ethics Journal 29 (4): 305–331.CrossRef
go back to reference Watson, Judith M., and David J. Torgerson. 2006. Increasing recruitment to randomised trials: A review of randomised controlled trials. BMC Medical Research Methodology 6 (1): 1–9.CrossRef Watson, Judith M., and David J. Torgerson. 2006. Increasing recruitment to randomised trials: A review of randomised controlled trials. BMC Medical Research Methodology 6 (1): 1–9.CrossRef
go back to reference Wertheimer, Alan. 2008. Exploitation in clinical research. In The Oxford textbook on the ethics of clinical research, ed. Ezekiel J. Emanuel, Robert A. Crouch, Christine C. Grady, Reidar K. Lie, Franklin G. Miller, and David D. Wendler, 201–210. New York: Oxford University Press. Wertheimer, Alan. 2008. Exploitation in clinical research. In The Oxford textbook on the ethics of clinical research, ed. Ezekiel J. Emanuel, Robert A. Crouch, Christine C. Grady, Reidar K. Lie, Franklin G. Miller, and David D. Wendler, 201–210. New York: Oxford University Press.
go back to reference Wertheimer, Alan, and Franklin G. Miller. 2008. Payment for research participation: A coercive offer? Journal of Medical Ethics 34 (5): 389–392.CrossRef Wertheimer, Alan, and Franklin G. Miller. 2008. Payment for research participation: A coercive offer? Journal of Medical Ethics 34 (5): 389–392.CrossRef
go back to reference Wilkinson, Martin, and Andrew Moore. 1997. Inducement in research. Bioethics 11 (5): 373–389.CrossRef Wilkinson, Martin, and Andrew Moore. 1997. Inducement in research. Bioethics 11 (5): 373–389.CrossRef
go back to reference Williams, Rebecca J., Tony Tse, Katelyn DiPiazza, and Deborah A. Zarin. 2015. Terminated trials in the ClinicalTrials.gov results database: Evaluation of availability of primary outcome data and reasons for termination. PLoS ONE 10 (5): e0127242.CrossRef Williams, Rebecca J., Tony Tse, Katelyn DiPiazza, and Deborah A. Zarin. 2015. Terminated trials in the ClinicalTrials.gov results database: Evaluation of availability of primary outcome data and reasons for termination. PLoS ONE 10 (5): e0127242.CrossRef
go back to reference Winter, Stuart S., Janet M. Page-Reeves, Kimberly A. Page, Emily Haozous, Angelica Solares, Carla N. Cordova, and Richard S. Larson. 2018. Inclusion of special populations in clinical research: Important considerations and guidelines. Journal of Clinical and Translational Research 4 (1): 56–69. Winter, Stuart S., Janet M. Page-Reeves, Kimberly A. Page, Emily Haozous, Angelica Solares, Carla N. Cordova, and Richard S. Larson. 2018. Inclusion of special populations in clinical research: Important considerations and guidelines. Journal of Clinical and Translational Research 4 (1): 56–69.
Metadata
Title
The ethical anatomy of payment for research participants
Author
Joanna Różyńska
Publication date
24-05-2022
Publisher
Springer Netherlands
Published in
Medicine, Health Care and Philosophy / Issue 3/2022
Print ISSN: 1386-7423
Electronic ISSN: 1572-8633
DOI
https://doi.org/10.1007/s11019-022-10092-1

Other articles of this Issue 3/2022

Medicine, Health Care and Philosophy 3/2022 Go to the issue

Scientific Contribution

The hermeneutics of symptoms